GoodRx Holdings, Inc. - GDRX STOCK NEWS

Welcome to our dedicated page for GoodRx Holdings news (Ticker: GDRX), a resource for investors and traders seeking the latest updates and insights on GoodRx Holdings stock.

GoodRx Holdings, Inc. (Symbol: GDRX) is a leading consumer-focused digital healthcare platform committed to reducing the cost of healthcare in the United States. The company operates a price comparison platform that provides consumers with current, geographically relevant pricing for prescription medications. GoodRx gathers prices from multiple sources, offering powerful savings tips, valuable discounts, and negotiable price codes for prescriptions at virtually every pharmacy across the US.

GoodRx serves millions of Americans each month, including thousands of physicians who use the platform to help their patients. To date, the company has saved users over $3 billion on their prescription drug costs. Despite this success, GoodRx continues to work toward making prescriptions affordable for all Americans.

The company's core revenue stream comes from pharmacy benefit managers (PBMs), who manage formularies and prescription transactions. GoodRx also offers additional healthcare products and services such as pharma manufacturer solutions, subscription plans, and telehealth services. Their platform extends beyond individual consumers to include solutions for health plans, payors, and PBMs through an easy-to-use website and mobile app experience known as GoodRx for Benefits.

As GoodRx continues to innovate and expand its offerings, it remains dedicated to its mission of lowering healthcare costs and making essential medications accessible to everyone in the US. Stay updated with the latest news and developments from GoodRx to see how they are transforming the healthcare landscape.

05/09/2024 06:05 AM

News

GoodRx Reports First Quarter 2024 Results

Rhea-AI Summary

GoodRx Holdings, Inc. reported financial results for the first quarter of 2024. Revenue increased by 8% to $197.9 million, with a net loss of $1.0 million. Adjusted EBITDA was $62.8 million. The company focuses on capital allocation, share repurchases, and M&A. GoodRx anticipates revenue growth for the second quarter and full year 2024.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-8.94%

Tags

04/24/2024 08:00 AM

News

GoodRx Announces Date for 2024 Investor Day

Rhea-AI Summary

GoodRx Holdings, Inc. (Nasdaq: GDRX) announced the date for its 2024 Investor Day on May 15, 2024, in New York City. The event will feature presentations by the Interim CEO, CFO, and other leaders, discussing business drivers, growth strategy, and a Q&A session. A live webcast link will be available on the investor relations website.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-0.14%

Tags

04/11/2024 04:09 PM

News

GoodRx Announces Date for First Quarter 2024 Earnings Release and Conference Call

Rhea-AI Summary

GoodRx Holdings, Inc. (Nasdaq: GDRX) announced the release of its first quarter 2024 financial results on May 9, 2024. The Company will hold a conference call and webcast to discuss the results and business outlook.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-1.3%

Tags

03/14/2024 08:00 AM

News

GoodRx Interim CEO Extends Commitment to Company

Rhea-AI Summary

GoodRx Holdings, Inc. announces board resignations with Interim CEO Scott Wagner extending commitment. Directors Stephen LeSieur and Adam Karol resign effective March 14 and March 22, 2024. Company expresses gratitude for their contributions and looks forward to continued growth.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-5.18%

Tags

02/29/2024 06:02 AM

News

GoodRx Reports Fourth Quarter and Full Year 2023 Results

Rhea-AI Summary

GoodRx Holdings, Inc. released its financial results for Q4 and full year 2023, showing revenue of $196.6 million in Q4 and $750.3 million for the year. The company reported a net loss of $25.9 million in Q4 and $8.9 million for the full year. Adjusted EBITDA was $57.3 million in Q4 and $217.4 million for the year.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

20.4%

Tags

02/20/2024 04:05 PM

News

GoodRx to Participate in Upcoming Investor Conferences

Rhea-AI Summary

GoodRx Holdings, Inc. (GDRX) executives will participate in investor conferences in March 2024, providing a live webcast and archived recordings for investors.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

1.71%

Tags

02/01/2024 04:05 PM

News

GoodRx Announces Date for Fourth Quarter and Full Year 2023 Earnings Release and Conference Call

Rhea-AI Summary

GoodRx Holdings, Inc. (Nasdaq: GDRX) announced the release of its fourth-quarter and full-year 2023 financial results, along with plans for a conference call and webcast to discuss the results and the Company’s business outlook.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

1.14%

Tags

01/22/2024 02:15 PM

News

GoodRx Announces Proposed Refinancing of First Lien Credit Facilities

Rhea-AI Summary

GoodRx Holdings, Inc. (Nasdaq: GDRX) plans to refinance its first lien credit facilities, seeking to refinance its first lien term loan facility and amend its revolving credit facility to extend the maturity date. The terms of the proposed refinancing will be disclosed upon completion, expected during the Company’s first fiscal quarter of 2024. The proposed transaction is subject to the effectiveness of definitive documentation for the credit facilities and customary closing conditions, with no assurance of occurrence or specific terms.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

2.18%

Tags

01/11/2024 09:00 AM

News

The GoodRx Effect: Delivering a Transformative Impact on the U.S. Healthcare System through Prescription Savings

Rhea-AI Summary

GoodRx (NASDAQ: GDRX) has saved Americans $65 billion and the healthcare system over $5 billion by improving medication access and adherence, positively impacting health outcomes and significantly reducing costs within the healthcare system. The company has saved consumers more than $65 billion on brand-name and generic prescription medications, with users saving an average of 82% on retail prices for prescription medications in the last year.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

1.55%

Tags

01/10/2024 09:01 AM

News

GoodRx Announces Preliminary Fourth Quarter and Full Year 2023 Results and Early Expectations for First Quarter and Full Year 2024

Rhea-AI Summary

GoodRx Holdings, Inc. (Nasdaq: GDRX) reported preliminary unaudited financial results for Q4 and full year 2023. Q4 Revenue expected to be $195-197 million, a 6-7% increase YoY. Full year 2023 Revenue expected to be $749-751 million, a 2% decrease YoY. Adjusted EBITDA Margins expected to be at the upper end of previous guidance range. The increase in revenue was primarily driven by organic growth in Prescription Transactions Revenue.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

13.31%

Tags

FAQ

What is the current stock price of GoodRx Holdings (GDRX)?

The current stock price of GoodRx Holdings (GDRX) is $4.9 as of November 22, 2024.

What is the market cap of GoodRx Holdings (GDRX)?

The market cap of GoodRx Holdings (GDRX) is approximately 1.8B.

What does GoodRx Holdings, Inc. do?

GoodRx Holdings, Inc. is a digital healthcare platform that helps reduce the cost of prescriptions by offering price comparisons, discounts, and savings tips for medications across the US.

How does GoodRx save money on prescriptions?

GoodRx collects and compares current prescription prices from various sources, providing users with discounts and negotiable price codes that can be used at nearly every pharmacy in the US.

Who benefits from using GoodRx?

Millions of Americans, including those with insurance or Medicare, benefit from using GoodRx to find affordable prescription prices. Physicians also use GoodRx to help their patients save money.

How much has GoodRx saved Americans so far?

GoodRx has saved Americans over $3 billion on their prescription drug costs.

What additional services does GoodRx offer?

Besides price comparison and discounts, GoodRx offers pharma manufacturer solutions, subscription plans, telehealth services, and GoodRx for Benefits, which provides solutions for health plans, payors, and PBMs.

How does GoodRx generate revenue?

GoodRx generates revenue primarily from pharmacy benefit managers (PBMs) who manage formularies and prescription transactions. The company also earns from its additional healthcare products and services.

What is GoodRx for Benefits?

GoodRx for Benefits is a technology solution that provides health plans, payors, and PBMs with an easy-to-use website and mobile app experience to manage and reduce healthcare costs.

Is GoodRx available as a mobile app?

Yes, GoodRx offers a mobile app that allows users to compare prescription prices, find discounts, and access savings tips on the go.

Why should I use GoodRx if I already have insurance?

Even with insurance or Medicare, prescription costs can be high. GoodRx helps you find lower prices and better discounts, making medications more affordable.

Where can I learn more about GoodRx?

Visit www.goodrx.com to learn more about how GoodRx can help you save on prescriptions and explore their additional healthcare services.

GoodRx Holdings, Inc.

Nasdaq:GDRX

GDRX Rankings

#2101 Ranked by Market Cap

N/A Ranked by Dividends

GDRX Stock Data

Market Cap 1.75B

Float 88.30M

Insiders Ownership 11.9%

Institutions Ownership 70.75%

Short Percent 2.28%

Industry Health Information Services

Sector Services-computer Processing & Data Preparation

Website Link

Country United States of America

City SANTA MONICA